title: Pseudointernuclear ophthalmoplegia as a presenting feature of ocular myasthenia gravis.
authors.affiliation: Department of Neurology, Erasmus Medical Center, Rotterdam, The Netherlands.
authors.forename: Britta
authors.initials: B
authors.lastname: Nijsse
authors.affiliation: Department of Ophthalmology, Rotterdam Eye Hospital, Rotterdam, The Netherlands.
authors.forename: Marijke Wefers
authors.initials: MW
authors.lastname: Bettink
authors.affiliation: Department of Neurology, Erasmus Medical Center, Rotterdam, The Netherlands.
authors.forename: Rinze F
authors.initials: RF
authors.lastname: Neuteboom
mesh_terms: D000293:Adolescent; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D009157:Myasthenia Gravis / Q000150:complications* / Q000188:drug therapy; D009759:Nystagmus, Pathologic / Q000188:drug therapy / Q000209:etiology; D009886:Ophthalmoplegia / Q000188:drug therapy / Q000209:etiology*; D011729:Pyridostigmine Bromide / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D002800:Cholinesterase Inhibitors; D011729:Pyridostigmine Bromide